United States · FDA National Drug Code directory
OXTELLAR XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17772-122_5b887c21-e4f8-1936-e063-6294a90a6db7
- Product NDC
- 17772-122
- Form
- TABLET
- Composition / generic term
- OXCARBAZEPINE
- Labeler
- Supernus Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130117
- Source listing expiry
- 20271231
Source-listed ingredients
- OXCARBAZEPINE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (17772-122-01) · 17772-122-01
- 7 TABLET in 1 BOTTLE (17772-122-07) · 17772-122-07
- 5 TABLET in 1 BLISTER PACK (17772-122-10) · 17772-122-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →